FTCD-AS1

Across TCGA pan-cancer cohorts, FTCD-AS1 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of FTCD-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in cholangiocarcinoma (CHOL), where FTCD-AS1 RNA is repressed in tumor relative to normal tissue. In most cancer types FTCD-AS1 is over-expressed in tumor, although a few such as CHOL and KICH show the opposite, repressed pattern.

CHOL, KICH, and LUSC are the cancer types where FTCD-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in FTCD-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CHOL	Male	All	−0.811	.004	4	view →
KICH	All	All	−0.111	.001	4	view →
LUSC	All	II,III,IV	+0.104	.006	4	view →
UCEC	All	IV	+0.605	<.001	2	view →
LIHC	Female	III,IV	+0.290	.039	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

FTCD-AS1–CHOL

Open the CHOL breakdown →